Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Akan

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
Vaccine|February 23, 2016
Factors affecting uptake of influenza vaccination among family physiciansH Akan, E Yavuz, M E Yayla, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1992
P-glycoprotein expression in refractory hematological neoplasms and circumvention of resistance with verapamil or cyclosporine A containing protocolsM Beksaç, H Akan, H Koç, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
An Extra Benefit of Allogeneic Peripheral Blood Stem Cell Transplantation in a Patient with Lymphoblastic Lymphoma: Cure of Thalassemia MinorH Çelebi, C Üstün, M Arat, et al.
Haematologica|October 17, 2001
Extramedullary relapse following allogeneic stem cell transplantation in acute promyelocytic leukemia: the role of ATRAC Ustün, M Arat, H Celebi, et al.
International Journal of Hematology|December 24, 1997
HLA DR2: a predictive marker in response to cyclosporine therapy in aplastic anemiaO Ihan, M Beksaç, O Arslan, et al.
Haematologia|January 1, 1997
Administration of MINE protocol in untreated patients with intermediate and high grade non-Hodgkin's lymphomaI Aydogdu, H Koc, O Ilhan, et al.
Scandinavian Journal of Infectious Diseases|January 5, 2002
Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter studyM Erman, M Akova, H Akan, et al.
Blood|September 15, 1996
Is there an increased risk of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation?H Koc, G Gürman, O Arslan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2021
Assessment of the Role of 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Fungal Infections in AdultsF Lamoth, H Akan, D Andes, et al.
Bone Marrow Transplantation|September 9, 2004
High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma -- a retrospective evaluationT Demirer, M Ayli, T Fen, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
Vaccine|February 23, 2016
Factors affecting uptake of influenza vaccination among family physiciansH Akan, E Yavuz, M E Yayla, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1992
P-glycoprotein expression in refractory hematological neoplasms and circumvention of resistance with verapamil or cyclosporine A containing protocolsM Beksaç, H Akan, H Koç, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
An Extra Benefit of Allogeneic Peripheral Blood Stem Cell Transplantation in a Patient with Lymphoblastic Lymphoma: Cure of Thalassemia MinorH Çelebi, C Üstün, M Arat, et al.
Haematologica|October 17, 2001
Extramedullary relapse following allogeneic stem cell transplantation in acute promyelocytic leukemia: the role of ATRAC Ustün, M Arat, H Celebi, et al.
International Journal of Hematology|December 24, 1997
HLA DR2: a predictive marker in response to cyclosporine therapy in aplastic anemiaO Ihan, M Beksaç, O Arslan, et al.
Haematologia|January 1, 1997
Administration of MINE protocol in untreated patients with intermediate and high grade non-Hodgkin's lymphomaI Aydogdu, H Koc, O Ilhan, et al.
Scandinavian Journal of Infectious Diseases|January 5, 2002
Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter studyM Erman, M Akova, H Akan, et al.
Blood|September 15, 1996
Is there an increased risk of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation?H Koc, G Gürman, O Arslan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2021
Assessment of the Role of 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Fungal Infections in AdultsF Lamoth, H Akan, D Andes, et al.
Bone Marrow Transplantation|September 9, 2004
High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma -- a retrospective evaluationT Demirer, M Ayli, T Fen, et al.
Pageof 11